Andrew Christopher Wiechert, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Stem Cells | 5 | 2019 | 1357 | 0.570 |
Why?
|
Ovarian Neoplasms | 5 | 2019 | 4906 | 0.440 |
Why?
|
Cisplatin | 2 | 2017 | 1661 | 0.430 |
Why?
|
Green Fluorescent Proteins | 2 | 2016 | 2072 | 0.170 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8635 | 0.170 |
Why?
|
Mice, SCID | 4 | 2018 | 2633 | 0.160 |
Why?
|
Genital Neoplasms, Female | 1 | 2024 | 539 | 0.160 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2018 | 185 | 0.140 |
Why?
|
Perioperative Period | 2 | 2016 | 252 | 0.140 |
Why?
|
Postoperative Complications | 2 | 2016 | 15880 | 0.130 |
Why?
|
Connexins | 1 | 2018 | 355 | 0.130 |
Why?
|
Time-Lapse Imaging | 1 | 2016 | 195 | 0.120 |
Why?
|
Mice, Inbred NOD | 2 | 2016 | 1839 | 0.120 |
Why?
|
Obesity | 1 | 2016 | 13065 | 0.110 |
Why?
|
Genes, Reporter | 1 | 2015 | 1525 | 0.090 |
Why?
|
Morbidity | 1 | 2015 | 1760 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2013 | 489 | 0.080 |
Why?
|
Cell Line, Tumor | 4 | 2019 | 17149 | 0.080 |
Why?
|
Endometrial Neoplasms | 1 | 2017 | 1382 | 0.070 |
Why?
|
Transplantation, Heterologous | 1 | 2016 | 2393 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5803 | 0.060 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2017 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13708 | 0.060 |
Why?
|
Carcinoma | 1 | 2013 | 2341 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2016 | 14480 | 0.040 |
Why?
|
RNA | 1 | 2010 | 2727 | 0.040 |
Why?
|
Patient Readmission | 1 | 2013 | 3308 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2019 | 59680 | 0.040 |
Why?
|
Hypertension, Pulmonary | 1 | 2010 | 1605 | 0.040 |
Why?
|
Female | 10 | 2024 | 396943 | 0.040 |
Why?
|
Genome, Human | 1 | 2010 | 4453 | 0.030 |
Why?
|
Mammary Glands, Human | 1 | 2018 | 202 | 0.030 |
Why?
|
Aged | 6 | 2024 | 171520 | 0.030 |
Why?
|
Cost of Illness | 1 | 2024 | 1960 | 0.030 |
Why?
|
Middle Aged | 6 | 2024 | 223418 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9507 | 0.030 |
Why?
|
Infant | 1 | 2016 | 36497 | 0.030 |
Why?
|
Ileus | 1 | 2013 | 66 | 0.030 |
Why?
|
Child, Preschool | 1 | 2016 | 42623 | 0.030 |
Why?
|
Animals | 4 | 2018 | 169418 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2024 | 3629 | 0.020 |
Why?
|
Lung | 1 | 2010 | 10090 | 0.020 |
Why?
|
Humans | 9 | 2024 | 768451 | 0.020 |
Why?
|
Pleural Effusion | 1 | 2013 | 344 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2016 | 81834 | 0.020 |
Why?
|
Bone Morphogenetic Protein Receptors, Type II | 1 | 2010 | 72 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 60045 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6537 | 0.020 |
Why?
|
United States | 1 | 2016 | 73121 | 0.020 |
Why?
|
Child | 1 | 2016 | 80863 | 0.020 |
Why?
|
Adolescent | 1 | 2016 | 89168 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 30028 | 0.020 |
Why?
|
Adult | 3 | 2016 | 223542 | 0.020 |
Why?
|
Estrogen Receptor alpha | 1 | 2010 | 582 | 0.020 |
Why?
|
Mice | 3 | 2018 | 82045 | 0.020 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2010 | 520 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 2013 | 1544 | 0.010 |
Why?
|
Reoperation | 1 | 2013 | 4342 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5342 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12875 | 0.010 |
Why?
|
Signal Transduction | 2 | 2017 | 23638 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13324 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11249 | 0.010 |
Why?
|
Patient Discharge | 1 | 2013 | 3471 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54914 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2013 | 2591 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6521 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18478 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39430 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 65409 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11515 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2010 | 22293 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40271 | 0.010 |
Why?
|
Heart Failure | 1 | 2013 | 11857 | 0.000 |
Why?
|
Risk Factors | 1 | 2015 | 74915 | 0.000 |
Why?
|
Male | 2 | 2015 | 364781 | 0.000 |
Why?
|